New & Notable
FDA clears SleepioRx digital therapeutic for insomnia treatment
Big Health’s SleepioRx received FDA clearance. It is a digital cognitive behavioral therapy solution for chronic insomnia in adults that supports scalable access.
Biden administration releases National Heat Strategy
The strategy for 2024–2030 is supposed to promote heat planning, response, and resilience in the wake of extreme heat.
CDC issues health advisory on parvovirus B19
The organization cites a rising number of IgM antibodies for the disease, indicating higher infection rates.
CMS reaches agreements for lower prices of 10 drugs
The negotiated prices mark a 38–79% discount off of list prices that could save roughly $6 billion annually.
Insights
Insights is the research division of Xtelligent Healthcare Media. Our work aims to leverage Xtelligent’s diverse readership of healthcare professionals across various sectors of the industry to understand real-world challenges and identify effective solutions.
Access All Reports
Healthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
FDA approves first, only treatment for hypoparathyroidism
Yorvipath, manufactured by Acendis Pharma, was approved as the first and only treatment for hypoparathyroidism on August 12, 2024.
-
Breas Medical addresses formaldehyde in ventilators
Breas Medical initiates a nationwide correction to address potential formaldehyde exposure from Vivo 45 LS ventilators.
-
FDA approves first nasal spray for anaphylaxis
The FDA's approval of neffy offers a needle-free option for treating anaphylaxis, potentially improving patient access and compliance.
-
COVID-19 raises diabetes risk, while vaccination reduces impact
Research links COVID-19 to increased diabetes risk, underscoring that vaccination prevents severe cases and reduces the risk of diabetes.
-
CDC issues recommendations for contraceptive use
The CDC has updated its US Medical Eligibility Criteria for Contraceptive Use following a review of evidence earlier this year.
-
CDC issues warning on severe mpox strain, ongoing outbreaks
After WHO leaders announced the organization’s concerns about mpox outbreaks, the CDC warned about a strain originating in Africa.
Features
-
Recognizing the growing impact of climate change on infectious diseases
As climate change worsens, its growing impact on global health is becoming alarmingly evident, particularly through the spread of infectious diseases.
-
Exploring AI applications in radiology
Artificial intelligence can play many roles in radiology, including image analysis, interpretation, disease detection, and more.
-
Exploring FDA-approved birth control injections
Injectable contraceptives, like Depo-Provera and Depo-SubQ Provera 104, are name-brand FDA-approved hormonal birth control methods that prevent pregnancy.
-
Exploring FDA-approved vaginal rings for birth control
Vaginal rings, like NuvaRing, Annovera, and EluRyng, are FDA-approved hormonal birth control methods that effectively prevent pregnancy.